Cancer

[PRESSWIRE] London, UK – 13 June 2022 — Datar Cancer Genetics has announced its partnership with U.K. based The Cancer Screening Trust to offer its innovative, blood-based, cancer screening Trucheck solution. Datar Cancer Genetics has been at the forefront in developing greater insight into the cancer ecosystem and offering its innovative oncology focussed services to clinicians and patients globally.

[PRESSWIRE] LUBBOCK, TX — April 19, 2022 – NemaLife Inc., a DEA-registered and innovation-driven techbio company, has partnered with the research group led by Professor David E. Olson at the University of California, Davis to characterize the in vivo effects of several of their novel psychoplastogens.

[PRESSWIRE] Parma – 06 August, 2018 — New NDT study [1] shows that `normal´ pre-dialysis blood pressure measurement is not reliable. “Without performing extended ambulatory BP recordings (44h – 48h) we approvingly accept an error rate of about 30% in the diagnosis of hypertension in dialysis patients, a highly vulnerable patient group with a dramatically elevated cardiovascular risk. This is why EURECA-m recommends ambulatory blood pressure monitoring as gold standard for the diagnosis for hypertension in hemodialysis patient.”

[PRESSWIRE] WASHINGTON, May 31, 2018 /PRNewswire-USNewswire/ — As part of the upcoming American Society of Clinical Oncology’s (ASCO) annual conference in Chicago, June 1st through the 4th, the Cancer Support Community (CSC), a global nonprofit, will release three new research studies.

[PRESSWIRE] CAIRO, April 6, 2018 — Egypt has again chosen Elekta (EKTA-B.ST) to equip its Ministry of Health hospitals, including the National Cancer Institute (NCI) in Cairo.

[PRESSWIRE] REHOVOT, Israel, March 26, 2018 — Bladder EpiCheck™, a novel urine test, was presented in the annual meeting of the European Association of Urology (EAU) in Copenhagen, Denmark, which is the largest urology meeting in Europe.

[PRESSWIRE] SALT LAKE CITY – 07 August 2015 — Utah is falling short when it comes to supporting policies and passing legislation to prevent and reduce suffering and death from cancer.

[PRESSWIRE] London, United Kingdom – 04 February, 2016 — To mark World Cancer Day on the 4th February, the Deaf Health Charity SignHealth is launching videos on testicular cancer in British Sign Language (BSL). The charity has worked with male cancer charity Orchid – the UK’s leading charity working on behalf of everyone affected or interested in male cancer – to produce the series of ten videos. They explain what testicular cancer is and how it is diagnosed and treated.